The Combination of Temporal and Spatial Dose Fractionation in Microbeam Radiation Therapy
Open Access
- 10 March 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (3) , 678
Abstract
Background: Microbeam radiation therapy (MRT) is an advanced preclinical approach in radiotherapy that utilizes spatially fractionated dose distributions by collimating x-rays into micrometer-wide, planar beams. While the benefits of temporal fractionation are well established and widely incorporated into conventional radiotherapy protocols, the interplay between MRT and temporal dose fractionation remains largely unexplored. In this study, we investigate the effects of combining temporal and spatial dose fractionation by assessing clonogenic cell survival following temporally fractionated MRT with varying irradiation angles, compared to conventional broad-beam (BB) irradiation. Methods: A lung tumor cell line (A549) and a normal lung cell line (MRC-5) were irradiated with a total number of four fractions with a 24 h interval between each fraction. We compared a temporally fractionated BB regime to two temporally fractionated MRT schemes with either overlapping MRT fields or MRT fields with a 45° rotation per fraction. Subsequently, the clonogenic cell survival assay was used by analyzing the corresponding survival fractions (SFs). Results: The clonogenic survival of A549 tumor cells differed significantly between microbeam radiation therapy with rotation (MRT + R) and overlapping MRT. However, neither MRT + R nor overlapping MRT showed statistically significant differences compared to the broad-beam (BB) irradiation for A549. In contrast, the normal tissue cell line MRC-5 exhibited significantly higher clonogenic survival following both MRT + R and overlapping MRT compared to BB. Conclusions: This study demonstrates that combining temporal and spatial fractionation enhances normal tissue cell survival while maintaining equivalent tumor cell kill, potentially increasing the therapeutic index. Our findings support the feasibility of delivering temporally fractionated doses using different MRT modalities and provide clear evidence of the therapeutic benefits of temporally fractionated MRT.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG) (459947066, 416790481)
- Emmy Noether Programme (DFG) (459947066, 416790481)
This publication has 33 references indexed in Scilit:
- The Impact of Synchrotron Microbeam Radiation Therapy Combined With Broad Beam in a Preclinical Breast Cancer ModelAdvances in Radiation Oncology, 2024
- Recent advances in lung cancer research: unravelling the future of treatmentUpdates in Surgery, 2024
- Synchrotron Microbeam Radiation Therapy for the Treatment of Lung Carcinoma: A Preclinical StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
- A Brief Overview of the Preclinical and Clinical Radiobiology of Microbeam RadiotherapyClinical Oncology, 2021
- Establishment of Microbeam Radiation Therapy at a Small-Animal IrradiatorInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
- High resolution radiochromic film dosimetry: Comparison of a microdensitometer and an optical microscopePhysica Medica, 2019
- Lung cancer: Biology and treatment optionsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2015
- Microbeam radiation therapy: Clinical perspectivesPhysica Medica, 2015
- Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissueMutation Research - Reviews in Mutation Research, 2010
- Use of Normal Tissue Complication Probability Models in the ClinicInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010